Inventor · disambiguated record
Mathieu Ferrari
Also filed as: FERRARI MATHIEU
8 granted patents·12 pending applications·5 citations·filing 2017–2025
76Inventor score
Files withAUTOLUS LTD20
Top patents by PatentIndex Score
20 records- 0194US11590170B2Chimeric antigen receptorAUTOLUS LTD·Filed 2022·Granted Feb 28, 2023·3 cites·6 claims
- 0287US12049510B2Chimeric antigen receptorAUTOLUS LTD·Filed 2019·Granted Jul 30, 2024·2 cites·14 claims
- 0380US2025277047A1Chimeric antigen receptorAUTOLUS LTD·Filed 2024·Application pending·0 cites
- 0478US12454578B2Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen receptorsAUTOLUS LTD·Filed 2022·Granted Oct 28, 2025·0 cites·4 claims
- 0578US2025019434A1Chimeric antigen receptorAUTOLUS LTD·Filed 2024·Application pending·0 cites
- 0677US2025333505A1T-cell receptor constant region 1 antibody or t-cell receptor constant region 2 antibodyAUTOLUS LTD·Filed 2024·Application pending·0 cites
- 0770US11963981B2Chimeric antigen receptorAUTOLUS LTD·Filed 2019·Granted Apr 23, 2024·0 cites·16 claims
- 0868US11945867B2T-cell receptor constant region 1 antibody or T-cell receptor constant region 2 antibodyAUTOLUS LTD·Filed 2019·Granted Apr 2, 2024·0 cites·11 claims
- 0959US2025289891A1Anti-cd307e single-domain antibodies, uses thereof in car t-cell and for the treatment of diseasesAUTOLUS LTD·Filed 2022·Application pending·0 cites
- 1057US2025381224A1Car t-cells comprising an anti cd33, an anti cll1 and at least one further car anti cd123 and/or ftl3AUTOLUS LTD·Filed 2025·Application pending·0 cites
- 1156US2023330139A1Car t-cells comprising an anti cd33, an anti cll1 and at least one further car anti cd123 and/or ftl3AUTOLUS LTD·Filed 2019·Application pending·0 cites
- 1254US2023109275A1Trbc beta antibody conjugateAUTOLUS LTD·Filed 2021·Application pending·0 cites
- 1352US12241068B2CD79-specific chimeric antigen receptorAUTOLUS LTD·Filed 2019·Granted Mar 4, 2025·0 cites·3 claims
- 1452US2021363217A1CellAUTOLUS LTD·Filed 2019·Application pending·0 cites
- 1551US2023293647A1PolypeptideAUTOLUS LTD·Filed 2021·Application pending·0 cites
- 1651US2022242965A1Engineered t-cells co-expressing an anti-bcma car and an anti-ectoenzyme antibody and their use in the treatment of cancerAUTOLUS LTD·Filed 2020·Application pending·0 cites
- 1749US2021244762A1Car-t cells expressing an inhibitory anti-tgf-beta-receptor ii single domain antibodyAUTOLUS LTD·Filed 2019·Application pending·0 cites
- 1847US12496314B2Antigen-binding domainAUTOLUS LTD·Filed 2020·Granted Dec 16, 2025·0 cites·10 claims
- 1944US12325733B2Binding domainAUTOLUS LTD·Filed 2019·Granted Jun 10, 2025·0 cites·15 claims
- 2036US2019352409A1Chimeric antigen receptorAUTOLUS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mathieu Ferrari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →